Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Qiagen N.V. (NY: QGEN ) 43.75 +0.02 (+0.05%) Official Closing Price Updated: 7:00 PM EDT, Jun 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,002,329 Open 44.22 Bid (Size) 42.33 (1) Ask (Size) 44.68 (1) Prev. Close 43.73 Today's Range 43.62 - 44.50 52wk Range 34.74 - 47.70 Shares Outstanding 227,985,334 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Qiagen Unveils Plan For $1B Shareholder Returns, Major Product Launches June 17, 2024 QIAGEN announces a comprehensive growth strategy by 2028. The plan includes significant shareholder returns, new product launches, and a focus on digital and diagnostic advancements. Via Benzinga QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications May 30, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Performance YTD +0.23% +0.23% 1 Month -3.78% -3.78% 3 Month -0.59% -0.59% 6 Month +1.82% +1.82% 1 Year -5.04% -5.04% More News Read More QGEN Stock Earnings: Qiagen Beats EPS, Beats Revenue for Q1 2024 April 29, 2024 Via InvestorPlace US Stocks Set To Approach New Week With Caution Ahead Of Fed Meeting, Tech Earnings: Analyst Says 'Buy The Dip' Contingent On This Condition April 29, 2024 Via Benzinga Topics Economy Exposures Interest Rates Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week April 29, 2024 Via Benzinga Topics Stocks Exposures US Equities Will Earnings Cheer Continue This Week? All Eyes On Disney, Palantir, Robinhood While Reddit Gears Up For Debut Quarterly Report May 06, 2024 Via Benzinga Topics Stocks Exposures US Equities Earnings Scheduled For February 6, 2024 February 06, 2024 Via Benzinga Earnings Preview: Qiagen February 05, 2024 Via Benzinga US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday? April 29, 2024 Via Benzinga Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion January 17, 2024 Via Benzinga Qiagen's Health Odyssey: Expanding In Riyadh And Partnering In Public Projects January 03, 2024 Via Benzinga Where Qiagen Stands With Analysts December 07, 2023 Via Benzinga Analyst Expectations for Qiagen's Future November 02, 2023 Via Benzinga Preview: Qiagen's Earnings October 27, 2023 Via Benzinga Analyst Expectations for Qiagen's Future October 17, 2023 Via Benzinga Qiagen Has Steady Income And Defensive Growth Potential, Goldman Sachs Upgrades Stock December 07, 2023 Via Benzinga These Companies Helped The German DAX Index Hit Its All-time High December 06, 2023 Via Talk Markets Diagnostic Firm Qiagen's Q3 Earnings: Analyst Says Annual Projections Attainable Despite Macro Trends October 31, 2023 Via Benzinga QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer October 26, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Will Chart Analysts Notice Bad Omen on Qiagen's Chart April 11, 2023 Via Benzinga Earnings Scheduled For October 30, 2023 October 30, 2023 Via Benzinga Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year September 21, 2023 Via Benzinga Exposures COVID-19 Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement July 26, 2023 From Bio-Rad Laboratories, Inc. Via Business Wire Stocks That Hit 52-Week Lows On Tuesday September 19, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023 September 12, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
